Girard Partners’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $216K | Sell |
2,222
-23
| -1% | -$2.12K | 0.02% | 248 |
|
|
2024
Q1 | $202K | Buy |
+2,245
| New | +$190K | 0.02% | 260 |
|
|
2023
Q1 | – | Sell |
-2,673
| Closed | -$211K | – | 254 |
|
|
2022
Q4 | $211K | Buy |
+2,673
| New | +$200K | 0.02% | 252 |
|
|
2022
Q1 | – | Sell |
-2,661
| Closed | -$227K | – | 249 |
|
|
2021
Q4 | $227K | Sell |
2,661
-629
| -19% | -$49.1K | 0.02% | 218 |
|
|
2021
Q3 | $248K | Sell |
3,290
-663
| -17% | -$52.6K | 0.03% | 208 |
|
|
2021
Q2 | $321K | Sell |
3,953
-1,983
| -33% | -$162K | 0.04% | 195 |
|
|
2021
Q1 | $468K | Sell |
5,936
-2,324
| -28% | -$182K | 0.07% | 154 |
|
|
2020
Q4 | $706K | Sell |
8,260
-1,899
| -19% | -$157K | 0.11% | 128 |
|
|
2020
Q3 | $783K | Sell |
10,159
-7,367
| -42% | -$562K | 0.13% | 120 |
|
|
2020
Q2 | $1.28M | Sell |
17,526
-5,395
| -24% | -$383K | 0.23% | 92 |
|
|
2020
Q1 | $1.52M | Sell |
22,921
-238
| -1% | -$16.8K | 0.3% | 84 |
|
|
2019
Q4 | $1.59M | Buy |
23,159
+1,039
| +5% | +$70.8K | 0.26% | 93 |
|
|
2019
Q3 | $1.63M | Sell |
22,120
-151
| -0.7% | -$11K | 0.3% | 83 |
|
|
2019
Q2 | $1.6M | Sell |
22,271
-874
| -4% | -$62K | 0.28% | 85 |
|
|
2019
Q1 | $1.59M | Sell |
23,145
-301
| -1% | -$19.4K | 0.3% | 86 |
|
|
2018
Q4 | $1.4M | Sell |
23,446
-1,123
| -5% | -$70.3K | 0.29% | 83 |
|
|
2018
Q3 | $1.64M | Sell |
24,569
-4,529
| -16% | -$302K | 0.29% | 87 |
|
|
2018
Q2 | $1.89M | Buy |
29,098
+1,465
| +5% | +$95.8K | 0.36% | 78 |
|
|
2018
Q1 | $1.98M | Sell |
27,633
-639
| -2% | -$46K | 0.46% | 62 |
|
|
2017
Q4 | $2.13M | Sell |
28,272
-655
| -2% | -$47.8K | 0.41% | 72 |
|
|
2017
Q3 | $2.11M | Sell |
28,927
-437
| -1% | -$31.5K | 0.44% | 71 |
|
|
2017
Q2 | $2.18M | Buy |
29,364
+831
| +3% | +$61.7K | 0.47% | 66 |
|
|
2017
Q1 | $2.09M | Sell |
28,533
-17,351
| -38% | -$1.21M | 0.5% | 69 |
|
|
2016
Q4 | $3M | Buy |
45,884
+22,952
| +100% | +$1.57M | 0.87% | 40 |
|
|
2016
Q3 | $1.7M | Buy |
22,932
+541
| +2% | +$40K | 0.57% | 63 |
|
|
2016
Q2 | $1.64M | Sell |
22,391
-621
| -3% | -$44.2K | 0.62% | 55 |
|
|
2016
Q1 | $1.63M | Sell |
23,012
-3,801
| -14% | -$253K | 0.71% | 48 |
|
|
2015
Q4 | $1.79M | Sell |
26,813
-75
| -0.3% | -$4.99K | 0.86% | 40 |
|
|
2015
Q3 | $1.71M | Sell |
26,888
-660
| -2% | -$43.1K | 0.97% | 38 |
|
|
2015
Q2 | $1.8M | Buy |
27,548
+729
| +3% | +$49.5K | 1.01% | 37 |
|
|
2015
Q1 | $1.86M | Sell |
26,819
-637
| -2% | -$44K | 1.1% | 33 |
|
|
2014
Q4 | $1.9M | Buy |
27,456
+751
| +3% | +$50.7K | 1.19% | 29 |
|
|
2014
Q3 | $1.74M | Sell |
26,705
-679
| -2% | -$44.8K | 1.17% | 32 |
|
|
2014
Q2 | $1.87M | Sell |
27,384
-615
| -2% | -$41.2K | 1.29% | 25 |
|
|
2014
Q1 | $1.82M | Buy |
27,999
+4,016
| +17% | +$253K | 1.29% | 25 |
|
|
2013
Q4 | $1.56M | Buy |
+23,983
| New | +$1.53M | 1.24% | 28 |
|
Other funds holding CL
Girard Partners's CL Position: Q2 2024 in Review
Girard Partners reduced its Colgate-Palmolive (CL) stake by 1% in Q2 2024, selling an estimated $2.12K and leaving 2,222 shares worth $216K. The position accounts for 0.02% of the portfolio, ranked #248.
Girard Partners first reported a position in CL in Q4 2013 and has held it in 36 quarters since. The position peaked at $3M in Q4 2016. 1,819 funds tracked by Wall St. Rank hold CL as of Q2 2024.
- Girard Partners held 2,222 shares of Colgate-Palmolive worth $216K as of Q2 2024.
- Girard Partners sold 23 Colgate-Palmolive shares in Q2 2024, an estimated $2.12K.
- Colgate-Palmolive made up 0.02% of Girard Partners's portfolio in Q2 2024, its #248 holding.
- Girard Partners first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 36 quarters since.
- Girard Partners's Colgate-Palmolive position peaked at $3M in Q4 2016.
- 1,819 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.
Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.